Fertility and Sterility
Volume 79, Issue 2 , Pages 256-260 , February 2003

Effects of estrogen and psychological stress on plasma homocysteine levels

  • Noha H Farag, M.D.

      Affiliations

    • Departments of Psychiatry and Pediatrics, University of California, San Diego, San Diego, California, USA
    • Corresponding Author InformationReprint requests: Noha H. Farag, M.D., University of California, San Diego, Department of Psychiatry, 9500 Gilman Drive, DEPT 0804, La Jolla, California 92093-0804, USA (FAX: 619-543-7519).
    • ,
  • Bruce A Barshop, M.D., Ph.D.

      Affiliations

    • Departments of Psychiatry and Pediatrics, University of California, San Diego, San Diego, California, USA
    • ,
  • Paul J Mills, Ph.D.

      Affiliations

    • Departments of Psychiatry and Pediatrics, University of California, San Diego, San Diego, California, USA

Received 8 March 2002 ,Revised 4 September 2002 ,Accepted 4 September 2002.

References 

  1. Graham IM, Daly LE, Refsum HM, Robinson K. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277:1775–1781
  2. Kuller LH, Evans RW. Homocysteine, vitamins and cardiovascular disease. Circulation. 1998;98:196–199
  3. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230–236
  4. Harker LA, Slichter SJ, Scott CR, Ross R. Homocysteinemia. Vascular injury and arterial thrombosis. N Engl J Med. 1974;291:537–543
  5. Lentz SR, Malinow MR, Piegors DJ, Bhopatkar-Teredesai M, Faraci FM, Heistad DD. Consequences of hyperhomocysteinemia on vascular function in atherosclerotic monkeys. Arterioscler Thromb Vasc Biol. 1997;17:2930–2934
  6. Saab PG, Matthews KA, Stoney CM, McDonald RH. Premenopausal and postmenopausal women differ in their cardiovascular and neuroendocrine responses to behavioral stressors. Psychophysiology. 1989;26:270–280
  7. Ryan KJ. Estrogens and atherosclerosis. Clin Obstet Gynecol. 1976;19:805–815
  8. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease (a quantitative assessment of the epidemiologic evidence). Prev Med. 1991;20:47–63
  9. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, et al.  Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016–1037
  10. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health. 1998;19:55–72
  11. Moerman CJ, Witteman JC, Collette HJ, Gevers Leuven JA, Kluft C, Kenemans P, et al.  Hormone replacement therapy (a useful tool in the prevention of coronary artery disease in postmenopausal women?Working Group on Women and Cardiovascular Disease of the Netherlands Heart Foundation). Eur Heart J. 1996;17:658–666
  12. Fredrikson M, Matthews KA. Cardiovascular responses to behavioral stress and hypertension (a meta-analytic review). Ann Behav Med. 1990;12:30–39
  13. Wouters MG, Moorrees MT, van der Mooren MJ, Blom HJ, Boers GH, Schellekens LA, et al.  Plasma homocysteine and menopausal status. Euro J Clin Invest. 1995;25:801–805
  14. de Bree A, Verschuren VM, Blom HJ, de Graaf-Hess A, Trijbels FJ, Kromhout D. The homocysteine distribution ((Mis)judging the burden). J Clin Epidemiol. 2001;54:462–469
  15. Verhoef P, Meleady R, Daly LE, Graham IM, Robinson K, Boers GH. Homocysteine, vitamin status and risk of vascular disease (effects of gender and menopausal status. The European COMAC group). Eur Heart J. 1999;20:1234–1244
  16. Evio S, Tiitinen A, Turpeinen U, Ylikorkala O. Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels. Fertil Steril. 2000;74:1080–1083
  17. Man RY, Ting LK, Fan S, Lau MM, Siow YL, Chung YH, et al.  Effect of postmenopausal hormone replacement therapy on lipoprotein and homocysteine levels in Chinese women. Mol Cell Biochem. 2001;225:129–134
  18. Stoney CM. Plasma homocysteine levels increase in women during psychological stress. Life Sci. 1999;64:2359–2365
  19. Mills PJ, Ziegler MG, Nelesen RA, Kennedy BP. The effects of menstrual cycle, race and gender on adrenergic receptors and agonists. Clin Pharmacol Thera. 1996;60:99–104
  20. Magera MJ, Lacey JM, Casetta B, Rinaldo P. Method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry. Clin Chem. 1999;45:1517–1522
  21. Andersson A, Brattstrom L, Israelson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender and menopausal status. Eur J Clin Invest. 1992;22:79–87
  22. Brattstrom L, Israelsson B, Norrving B, Bergqvist D, Thorne J, Hultberg B, et al.  Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis. 1990;81:51–60
  23. Berg K, Malinow MR, Kierulf P, Upson B. Population variation and genetics of plasma homocysteine level. Clin Genet. 1992;41:315–321
  24. Dudman NP, Wilcken DE, Wang J, Lynch JF, Macey D, Lundberg P. Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb. 1993;13:1253–1260
  25. Mijatovic V, Kenemans P, Netelenbos JC, Jacobs C, Popp-Snijders C, Peters-Muller ER, et al.  Postmenopausal oral 17 β-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels. Fertil Steril. 1998;69:876–882
  26. van der Mooren MJ, Wouters MG, Blom HJ, Schellekens LA, Eskes TK, Rolland R. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur J Clin Invest. 1994;24:733–736
  27. Barnabei VM, Phillips TM, Hsia J. Plasma homocysteine in women taking hormone replacement therapy (the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial). J Womens Health Gend Based Med. 1999;8:1167–1172
  28. Estrada DA, Billett HH. Racial variation in fasting and random homocysteine levels. Am J Hematol. 2001;66:252–256
  29. Masser PA, Taylor LM, Porter JM. Importance of elevated plasma homocysteine levels as a risk factor for atherosclerosis. Ann Thorac Surg. 1994;58:1240–1246
  30. Welch GN, Loscalzo J. Homocysteine and atherothromosis. N Engl J Med. 1998;338:1042–1050
  31. Kang SS, Wong PW, Cook HY, Norusis M, Messer JV. Protein-bound homocysteine. A possible risk factor for coronary artery disease. J Clin Invest. 1986;77:1482–1486

☆ Supported by grants AG-13332, MO1-RR00827, and HL-57265 from the National Institutes of Health and an American Psychosomatic Society General Clinical Research Center Award.

PII: S0015-0282(02)04676-9

doi: 10.1016/S0015-0282(02)04676-9

Fertility and Sterility
Volume 79, Issue 2 , Pages 256-260 , February 2003

Article Tools